Curaleaf Holdings (CURLF) Gross Profit (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Gross Profit of $157.3 million for Q1 2026, up 1.11% year-on-year from $155.6 million in Q1 2025, and down 3.83% on a QoQ basis from $163.6 million in Q4 2025.
Curaleaf Holdings (CURLF) Gross Profit (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Gross Profit for 8 consecutive years, with $157.3 million the latest figure, recorded in Q1 2026.
- Quarterly Gross Profit rose 1.11% year-over-year to $157.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $633.1 million (changed 0.36% YoY) and the FY2025 annual result came in at $631.0 million, down 1.52% from the prior year.
- Gross Profit retreated to $157.3 million in Q1 2026 per CURLF's latest filing, from $163.6 million in the prior quarter.
- Over the last five years, Gross Profit for CURLF reached as high as $179.0 million in Q1 2022 and fell as low as $156192.0 in Q4 2023.
- A 5-year average of $146.6 million and a median of $159.7 million in 2025 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit slumped 99.8% — and 2024, when it surged 101628.64%.
- Year by year, Gross Profit stood at $78.1 million in 2022, then sank by 99.8% to $156192.0 in 2023, then jumped by 101628.64% to $158.9 million in 2024, then gained by 2.93% to $163.6 million in 2025, then dropped by 3.83% to $157.3 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $157.3 million, $163.6 million, and $159.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.29 Mn |
| Mar 31, 2026 | 157.29 Mn |
| Dec 31, 2025 | 163.55 Mn |
| Dec 31, 2025 | 163.55 Mn |
| Sep 30, 2025 | 159.74 Mn |
| Sep 30, 2025 | 159.74 Mn |
| Jun 30, 2025 | 152.55 Mn |
| Jun 30, 2025 | 152.55 Mn |
| Mar 31, 2025 | 155.57 Mn |
| Mar 31, 2025 | 155.57 Mn |
| Dec 31, 2024 | 158.89 Mn |
| Dec 31, 2024 | 158.89 Mn |
| Sep 30, 2024 | 160.52 Mn |
| Sep 30, 2024 | 160.52 Mn |
| Jun 30, 2024 | 160.47 Mn |
| Jun 30, 2024 | 160.47 Mn |
| Mar 31, 2024 | 160.90 Mn |
| Mar 31, 2024 | 160.90 Mn |
| Dec 31, 2023 | 156,192.00 |
| Dec 31, 2023 | 156,192.00 |